重组人源TNC诱导胰腺癌细胞系PANC1的EMT及迁移和侵袭

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (2): 167-172.

重组人源TNC诱导胰腺癌细胞系PANC1的EMT及迁移和侵袭

蔡隽^1,2, 沈文远³, 王慧², 谭珵¹, 赵秀梅¹, 沈啸洪^2*

1.天津市医药科学研究所肿瘤药物研发中心,天津 300020;
2.南开大学医学院,天津 300071;
3.天津医科大学总医院骨科,天津 300052

收稿日期:2019-07-29 修回日期:2019-12-02 出版日期:2020-02-05 发布日期:2020-02-05
通讯作者: ^*zebal2014@163.com
基金资助:
国家自然科学基金(31370861)

Recombinant human TNC induces EMT, migration and invasion of pancreatic cancer cell line PANC1

CAI Jun^1,2, SHEN Wen-yuan³, WANG Hui², TAN Cheng¹, ZHAO Xiu-mei¹, SHEN Xiao-hong^2*

1. Centre for Research and Development of Anti Tumor Drugs, Tianjin Institute of Medical and Pharmaceutical Science,Tianjin 300020;
2. School of Medicine, Nankai University,Tianjin 300071;
3. Department of Orthopaedics, Tianjin Medical University General Hospital, Tianjin 300052, China

Received:2019-07-29 Revised:2019-12-02 Online:2020-02-05 Published:2020-02-05
Contact: ^*zebal2014@163.com

摘要/Abstract

摘要： 目的构建人肌腱蛋白C(TNC)真核表达质粒,利用稳定过表达TNC的胰腺癌细胞系以及探索TNC在胰腺癌转移中的作用及分子机制。方法采用独特的引物设计方法构建TNC表达质粒,经转染和G418筛选获得稳定过表达TNC的胰腺癌PANC1细胞系。通过RT-qPCR和Western blot对细胞系中TNC的表达进行鉴定。采用Transwell小室法和Western blot检测TNC对细胞迁移、侵袭能力以及上皮间质转化(EMT)相关分子表达的影响。结果成功构建TNC质粒,稳定过表达TNC的PANC1细胞迁移、侵袭能力显著增强(P＜0.05),上皮标志物E-cadherin表达减少而间质标志物N-cadherin表达增加(P＜0.05)。结果 TNC真核表达质粒以及TNC稳定表达胰腺癌细胞系的建立,可用于TNC对细胞EMT、迁移和侵袭等方面的机制研究,也是研究TNC生物学功能和胰腺癌发生发展机制的基础。

关键词: 肌腱蛋白C, 胰腺癌, 迁移, 侵袭, 上皮间质转化

Abstract: Objective To construct human TNC expression plasmid for the investigation of the role of TNC in pancreatic cancer metastasis by using pancreatic cancer cell strain with stable over-expression of TNC. Methods TNC expression plasmid was constructed by unique primer design method, and then pancreatic cancer cell strain PANC1 with stable TNC expression were obtained by transfection and G418 screening. RT-qPCR and Western blot examined the expression of TNC. Transwell and Western blot were used to detecte the effects of TNC on cell migration, invasion and EMT-related molecules. Results TNC plasmid was successfully constructed. TNC promoted cell migration and invasion(P＜0.05), decreased epithelial marker E-cadherin expression and upregulated mesenchymal marker N-cadherin expression (P＜0.05). Conclusions The TNC expression plasmid and TNC stable expression pancreatic cancer cell strain may be used to explore the biological function of TNC and the pathogenesis of pancreatic cancer.

Key words: TNC, pancreatic cancer, migration, invasion, EMT

中图分类号:

R735.9

蔡隽, 沈文远, 王慧, 谭珵, 赵秀梅, 沈啸洪. 重组人源TNC诱导胰腺癌细胞系PANC1的EMT及迁移和侵袭[J]. 基础医学与临床, 2020, 40(2): 167-172.

CAI Jun, SHEN Wen-yuan, WANG Hui, TAN Cheng, ZHAO Xiu-mei, SHEN Xiao-hong. Recombinant human TNC induces EMT, migration and invasion of pancreatic cancer cell line PANC1[J]. Basic & Clinical Medicine, 2020, 40(2): 167-172.

参考文献

[1]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69: 7-34.
[2]Esposito I, Penzel R, Chaib-Harrireche M, et al. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis [J]. J Pathol, 2006, 208: 673-685.
[3]Cai J, Lu W, Du S, et al. Tenascin-C modulates cell cycle progression to enhance tumour cell proliferation through AKT/FOXO1 signalling in pancreatic cancer [J]. J Cancer, 2018, 9: 4449-4462.
[4]Whittle MC, Hingorani SR. Fibroblasts in pancreatic ductal adenocarcinoma: biological mechanisms and therapeutic targets [J]. Gastroenterology, 2019, 156: 2085-2096.
[5]Sun Z, Schwenzer A, Rupp T, et al. Tenascin-C promotes tumor cell migration and metastasis through integrin alpha9beta1-mediated YAP inhibition [J]. Cancer Res, 2018, 78: 950-961.
[6]Murakami T, Kikuchi H, Ishimatsu H, et al. Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis [J]. Br J Cancer, 2017, 117: 1360-1370.
[7]Kropac AC, Eshwar AK, Stephan R, et al. New insights on the role of the pLMST6 plasmid in listeria monocytogenes biocide tolerance and virulence [J]. Front Microbiol, 2019, 10. doi: 10.3389/fmicb.2019.01538.
[8]Zhou P, Li B, Liu F, et al. The epithelial to mesen-chymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer [J]. Mol Cancer, 2017, 16. doi: 10.1186/s12943-017-0624-9.
[9]Thomson TM, Balcells C, Cascante M. Metabolic plas-ticity and epithelial-mesenchymal transition [J]. J Clin Med, 2019, 8. doi: 10.3390/jcm8070967.
[10]Takahashi Y, Sawada G, Kurashige J, et al. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells [J]. Anticancer Res, 2013, 33: 1927-1934.
[11]Yang Z, Zhang C, Qi W, et al. Tenascin-C as a pro-gnostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and prolifera-tion [J]. Exp Mol Pathol, 2018, 105: 216-222.
[12]Yoshida T, Akatsuka T, Imanaka-Yoshida K. Tenascin-C and integrins in cancer [J]. Cell Adh Migr, 2015, 9: 96-104.

[1]	郑红, 陈晓霞, 韩李周, 陈苗, 皇甫娟. 降低lncRNA-RMRP表达抑制人肺癌细胞系A549的增殖和侵袭[J]. 基础医学与临床, 2024, 44(7): 974-978.
[2]	曹清文, 祁琳, 禹博, 田晨晨, 袁海宁, 王越. 红景天苷促进人血管内皮细胞系EA.hy926增殖与迁移[J]. 基础医学与临床, 2024, 44(7): 925-930.
[3]	贾安娜, 郭金鑫, 张璇, 战世佳, 于永波, 郭永丽, 常艳. TMEFF1对神经母细胞瘤细胞系增殖的调控[J]. 基础医学与临床, 2024, 44(5): 637-644.
[4]	宋可, 宋柯, 李静宇, 马伟, 杨晓葵. 小鼠卵母细胞减数分裂中心粒蛋白SAS-6的表达和亚细胞分布[J]. 基础医学与临床, 2024, 44(5): 651-657.
[5]	陆凯, 陆建菊, 郭文利, 黄建棋, 李志华. lncRNA VIM-AS5在人乳腺癌细胞系中的表达及对乳腺癌细胞增殖和迁移的影响[J]. 基础医学与临床, 2024, 44(4): 447-453.
[6]	郭泓江, 徐也婷, 张迪雅, 仇佳星, 王钰铖, 鞠瑞, 郭磊. 羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响[J]. 基础医学与临床, 2024, 44(4): 440-446.
[7]	方媛, 李轶, 王玮. CircRERE调节miR-128-3p/WEE1轴促进人多发性骨髓瘤细胞系增殖、迁移和侵袭[J]. 基础医学与临床, 2024, 44(2): 210-218.
[8]	汪洋, 欧阳倩, 吕浩, 唐景峰. 锌转运蛋白家族在胰腺癌中的作用[J]. 基础医学与临床, 2024, 44(10): 1455-1459.
[9]	代娣, 杨振丽, 夏雨佳, 卞晓翠, 刘玉琴. 稳定表达Cas9蛋白质、荧光蛋白质和荧光素酶的胰腺癌细胞株的建立及鉴定[J]. 基础医学与临床, 2024, 44(10): 1419-1427.
[10]	余洁, 马明磊, 张化冰, 平凡, 李伟, 许岭翎, 李玉秀. miR-139-5p增强二甲双胍抑制正常糖培养下人胰腺癌细胞系PANC-1增殖[J]. 基础医学与临床, 2024, 44(1): 8-15.
[11]	李江丽, 孙静, 唐一君, 郭君兰, 陈博, 郭胜男. Circ-DDX5靶向miR-3940抑制人乳腺癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2024, 44(1): 1-7.
[12]	苏拾香, 王语阳, 覃宗帅, 黄桂香, 徐键, 岑兰英, 覃月秋. miR-142-3p通过调控Hmgb1抑制雨蛙素诱导的大鼠胰腺外分泌细胞系AR42J凋亡[J]. 基础医学与临床, 2024, 44(1): 23-30.
[13]	唐一君, 王文龙, 李江丽, 杨欢, 孙静. LncRNA RP11-686D22.10与乳腺癌患者生存期相关并影响乳腺癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2023, 43(7): 1023-1029.
[14]	金晓霞, 陆晓云, 刘玉山, 梁李娜. SIRT2在膀胱尿路上皮癌中的表达、临床意义及其对癌细胞增殖、侵袭和迁移的影响[J]. 基础医学与临床, 2023, 43(7): 1090-1096.
[15]	曾燕坤, 洪小颖, 陈清林. 下调BECN1抑制人白血病细胞系THP-1增殖、侵袭和迁移[J]. 基础医学与临床, 2023, 43(7): 1104-1109.